MATLIN DAVID J bought TLSI
July 31, 2025 · Form 4 insider transaction
MATLIN DAVID J bought 330,000 shares of TriSalus Life Sciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 244 days after the transaction.
Direction
Acquired (buy-side)
Shares
330,000
Price
$0.00
Total value
N/A
InsiderMATLIN DAVID J
Role—
SecurityCommon Stock
Transaction codeC: Conversion of a derivative
Transaction dateJuly 31, 2025
Filing dateApril 1, 2026
Shares owned after1,271,944
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares received upon conversion of the Series A Preferred Stock (the "Preferred Stock") reported in Table II.